Literature DB >> 8462316

Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel.

G C Davies1, L X Feng, J R Newton, A Van Beek, H J Coelingh-Bennink.   

Abstract

The properties of a single contraceptive subdermal implant releasing 3-ketodesogestrel were assessed in fifteen women over twelve months. Serum levels of 3-ketodesogestrel were monitored regularly following insertion and after removal. The mean serum level of 3-ketodesogestrel was 245 pg/ml after 72 h (steady state) and 176 pg/ml after twelve months. All volunteers demonstrated ovulation inhibition throughout the study. Transient oestradiol peaks occurred during the study. No luteal activity was noted. The cervical mucus was rapidly rendered hostile to sperm migration. Two women withdrew from the study during the first six months for medical reasons. Both volunteers cited bleeding irregularity as the main cause, one complaining of oligomenorrhoea, the other of prolonged bleeding/spotting episodes. A small but significant increase in weight was noted during the study period.

Entities:  

Keywords:  Biology; Contraception; Contraception Research; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Implants; Contraceptive Methods; Contraceptive Mode Of Action; Desogestrel; Endocrine System; Family Planning; Genitalia; Genitalia, Female; Hormones; Menstruation; Ovarian Effects; Ovary; Ovulation Suppression; Physiology; Reproduction; Research Report; Urogenital System

Mesh:

Substances:

Year:  1993        PMID: 8462316     DOI: 10.1016/0010-7824(93)90042-6

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  3 in total

1.  Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: a prospective study.

Authors:  Jesus Hernandez-Juarez; Ethel A Garcia-Latorre; Manuel Moreno-Hernandez; Jose Fernando Moran-Perez; Miguel Angel Rodriguez-Escobedo; Gerardo Cogque-Hernandez; Rubén Julián-Nacer; Xochitl Hernandez-Giron; Rosalia Palafox-Gomez; Irma Isordia-Salas; Abraham Majluf-Cruz
Journal:  Reprod Health       Date:  2014-04-26       Impact factor: 3.223

2.  A rodent model of human dose-equivalent progestin-only implantable contraception.

Authors:  Heather C M Allaway; Roger A Pierson; Jesse Invik; Susan A Bloomfield
Journal:  Reprod Biol Endocrinol       Date:  2021-03-22       Impact factor: 5.211

3.  Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive.

Authors:  Heather Hohmann
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.